Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Aortic Aneurysm, Abdominal | 173 | 2023 | 1186 | 36.780 |
Why?
|
Endovascular Procedures | 214 | 2023 | 1979 | 36.290 |
Why?
|
Blood Vessel Prosthesis Implantation | 150 | 2023 | 1390 | 30.530 |
Why?
|
Carotid Stenosis | 62 | 2023 | 854 | 16.200 |
Why?
|
Endarterectomy, Carotid | 58 | 2023 | 546 | 15.200 |
Why?
|
Vascular Surgical Procedures | 71 | 2023 | 1475 | 12.730 |
Why?
|
Aortic Rupture | 42 | 2023 | 310 | 12.520 |
Why?
|
Stents | 117 | 2023 | 3280 | 11.570 |
Why?
|
Peripheral Arterial Disease | 59 | 2023 | 1188 | 10.360 |
Why?
|
Lower Extremity | 42 | 2023 | 1158 | 8.140 |
Why?
|
Ischemia | 43 | 2023 | 1907 | 7.460 |
Why?
|
Aortic Aneurysm, Thoracic | 22 | 2023 | 686 | 7.200 |
Why?
|
Angioplasty | 31 | 2021 | 364 | 7.080 |
Why?
|
Blood Vessel Prosthesis | 41 | 2023 | 933 | 6.970 |
Why?
|
Femoral Artery | 38 | 2023 | 845 | 6.870 |
Why?
|
Carotid Artery Diseases | 25 | 2023 | 882 | 6.810 |
Why?
|
Vascular Grafting | 15 | 2019 | 142 | 5.350 |
Why?
|
Intermittent Claudication | 19 | 2023 | 309 | 4.870 |
Why?
|
Postoperative Complications | 108 | 2023 | 15295 | 4.830 |
Why?
|
Treatment Outcome | 288 | 2023 | 63114 | 4.820 |
Why?
|
Stroke | 71 | 2023 | 9981 | 4.620 |
Why?
|
Risk Factors | 280 | 2023 | 72290 | 4.510 |
Why?
|
Time Factors | 215 | 2023 | 40075 | 4.440 |
Why?
|
Angioplasty, Balloon | 21 | 2023 | 653 | 4.100 |
Why?
|
Chi-Square Distribution | 70 | 2022 | 3508 | 3.960 |
Why?
|
Risk Assessment | 143 | 2023 | 23338 | 3.920 |
Why?
|
Catheterization, Peripheral | 12 | 2021 | 345 | 3.890 |
Why?
|
Spinal Cord Ischemia | 7 | 2023 | 93 | 3.880 |
Why?
|
Retrospective Studies | 252 | 2023 | 77449 | 3.600 |
Why?
|
Registries | 82 | 2022 | 8089 | 3.410 |
Why?
|
Endoleak | 19 | 2023 | 106 | 3.320 |
Why?
|
Thoracic Injuries | 7 | 2023 | 272 | 3.210 |
Why?
|
Vascular System Injuries | 8 | 2023 | 250 | 3.090 |
Why?
|
Aged, 80 and over | 181 | 2023 | 57776 | 3.000 |
Why?
|
Limb Salvage | 30 | 2023 | 433 | 2.990 |
Why?
|
Popliteal Artery | 13 | 2022 | 317 | 2.730 |
Why?
|
Aged | 288 | 2023 | 163280 | 2.720 |
Why?
|
Quality Indicators, Health Care | 19 | 2021 | 1831 | 2.710 |
Why?
|
Databases, Factual | 75 | 2022 | 7729 | 2.710 |
Why?
|
Aortic Diseases | 10 | 2023 | 742 | 2.590 |
Why?
|
Patient Selection | 42 | 2023 | 4215 | 2.560 |
Why?
|
Wounds, Nonpenetrating | 8 | 2023 | 794 | 2.540 |
Why?
|
Aorta, Thoracic | 12 | 2023 | 1082 | 2.530 |
Why?
|
United States | 157 | 2024 | 69872 | 2.320 |
Why?
|
Aneurysm | 7 | 2022 | 339 | 2.280 |
Why?
|
Hospital Mortality | 55 | 2023 | 5317 | 2.280 |
Why?
|
Odds Ratio | 60 | 2020 | 9849 | 2.140 |
Why?
|
Multivariate Analysis | 62 | 2018 | 12245 | 2.040 |
Why?
|
Aorta, Abdominal | 12 | 2020 | 646 | 1.990 |
Why?
|
Logistic Models | 67 | 2020 | 13408 | 1.970 |
Why?
|
Male | 294 | 2023 | 350118 | 1.910 |
Why?
|
Humans | 421 | 2024 | 744343 | 1.880 |
Why?
|
Blood Loss, Surgical | 10 | 2020 | 662 | 1.870 |
Why?
|
Health Status Disparities | 12 | 2021 | 1797 | 1.860 |
Why?
|
Female | 297 | 2023 | 380194 | 1.810 |
Why?
|
Eligibility Determination | 3 | 2021 | 403 | 1.730 |
Why?
|
Mesenteric Vascular Occlusion | 4 | 2019 | 97 | 1.720 |
Why?
|
Healthcare Disparities | 18 | 2021 | 3158 | 1.710 |
Why?
|
Prosthesis Design | 23 | 2022 | 2110 | 1.690 |
Why?
|
Reoperation | 31 | 2022 | 4201 | 1.670 |
Why?
|
Decision Support Techniques | 10 | 2021 | 1956 | 1.650 |
Why?
|
Protamines | 3 | 2021 | 106 | 1.630 |
Why?
|
Aortography | 11 | 2023 | 437 | 1.620 |
Why?
|
Blood Transfusion | 9 | 2022 | 1301 | 1.550 |
Why?
|
Iliac Aneurysm | 5 | 2021 | 38 | 1.540 |
Why?
|
Thromboembolism | 3 | 2022 | 986 | 1.480 |
Why?
|
Saphenous Vein | 5 | 2020 | 532 | 1.470 |
Why?
|
Quality Improvement | 15 | 2021 | 3749 | 1.460 |
Why?
|
Ischemic Attack, Transient | 9 | 2022 | 935 | 1.440 |
Why?
|
Medicare | 35 | 2023 | 6566 | 1.430 |
Why?
|
Retroperitoneal Space | 4 | 2022 | 176 | 1.420 |
Why?
|
Credentialing | 2 | 2020 | 126 | 1.370 |
Why?
|
Cardiovascular Agents | 7 | 2022 | 850 | 1.350 |
Why?
|
Middle Aged | 175 | 2023 | 213383 | 1.340 |
Why?
|
Vascular Patency | 26 | 2023 | 886 | 1.270 |
Why?
|
Propensity Score | 14 | 2023 | 1781 | 1.270 |
Why?
|
Aortic Aneurysm | 4 | 2021 | 643 | 1.230 |
Why?
|
Peripheral Vascular Diseases | 9 | 2022 | 550 | 1.210 |
Why?
|
Patient Readmission | 10 | 2020 | 3114 | 1.170 |
Why?
|
Aneurysm, Ruptured | 4 | 2022 | 452 | 1.160 |
Why?
|
Kaplan-Meier Estimate | 33 | 2021 | 6538 | 1.150 |
Why?
|
Vascular Diseases | 5 | 2022 | 1161 | 1.140 |
Why?
|
Radiography, Interventional | 3 | 2018 | 1095 | 1.130 |
Why?
|
Blood Grouping and Crossmatching | 2 | 2017 | 107 | 1.130 |
Why?
|
Wound Healing | 8 | 2020 | 2785 | 1.110 |
Why?
|
Postoperative Hemorrhage | 3 | 2020 | 413 | 1.100 |
Why?
|
Leg | 7 | 2013 | 1116 | 1.090 |
Why?
|
Renal Artery | 5 | 2017 | 398 | 1.060 |
Why?
|
Patient Discharge | 10 | 2023 | 3313 | 1.050 |
Why?
|
Veins | 7 | 2022 | 770 | 1.040 |
Why?
|
Specialization | 5 | 2022 | 777 | 1.040 |
Why?
|
Arteries | 8 | 2023 | 1119 | 1.020 |
Why?
|
Arterial Occlusive Diseases | 9 | 2020 | 793 | 1.010 |
Why?
|
Length of Stay | 29 | 2020 | 6309 | 1.010 |
Why?
|
Graft Occlusion, Vascular | 8 | 2019 | 549 | 0.990 |
Why?
|
Wound Infection | 2 | 2017 | 242 | 0.960 |
Why?
|
Ultrasonography, Interventional | 4 | 2019 | 1486 | 0.950 |
Why?
|
Predictive Value of Tests | 27 | 2021 | 15076 | 0.940 |
Why?
|
Sex Factors | 24 | 2021 | 10397 | 0.940 |
Why?
|
Emergencies | 6 | 2021 | 1170 | 0.940 |
Why?
|
Heparin Antagonists | 2 | 2020 | 32 | 0.930 |
Why?
|
Mesenteric Artery, Superior | 4 | 2018 | 101 | 0.920 |
Why?
|
Carotid Arteries | 9 | 2023 | 952 | 0.910 |
Why?
|
Asymptomatic Diseases | 14 | 2021 | 551 | 0.890 |
Why?
|
Practice Guidelines as Topic | 11 | 2022 | 7279 | 0.890 |
Why?
|
Unnecessary Procedures | 2 | 2017 | 432 | 0.890 |
Why?
|
Proportional Hazards Models | 29 | 2018 | 12354 | 0.870 |
Why?
|
Carotid Artery, Common | 3 | 2023 | 183 | 0.860 |
Why?
|
Diabetes Mellitus | 6 | 2024 | 5751 | 0.850 |
Why?
|
Punctures | 9 | 2021 | 374 | 0.850 |
Why?
|
Angiography | 6 | 2023 | 1639 | 0.830 |
Why?
|
Embolization, Therapeutic | 9 | 2020 | 1392 | 0.830 |
Why?
|
Retreatment | 12 | 2021 | 610 | 0.820 |
Why?
|
Mass Screening | 7 | 2020 | 5255 | 0.790 |
Why?
|
Groin | 2 | 2019 | 104 | 0.780 |
Why?
|
Age Factors | 29 | 2021 | 18370 | 0.780 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2021 | 3255 | 0.760 |
Why?
|
Comorbidity | 24 | 2021 | 10388 | 0.760 |
Why?
|
Embolism | 3 | 2023 | 408 | 0.760 |
Why?
|
Endarterectomy | 9 | 2017 | 195 | 0.750 |
Why?
|
Device Removal | 4 | 2021 | 656 | 0.750 |
Why?
|
Balloon Occlusion | 2 | 2020 | 126 | 0.740 |
Why?
|
Liver Cirrhosis | 2 | 2021 | 1863 | 0.730 |
Why?
|
Myocardial Infarction | 26 | 2023 | 11727 | 0.720 |
Why?
|
Clinical Enzyme Tests | 1 | 2020 | 115 | 0.720 |
Why?
|
Subclavian Artery | 1 | 2020 | 130 | 0.700 |
Why?
|
Kidney Diseases | 5 | 2022 | 2149 | 0.700 |
Why?
|
Learning Curve | 3 | 2019 | 208 | 0.700 |
Why?
|
Paclitaxel | 7 | 2022 | 1708 | 0.680 |
Why?
|
Chronic Disease | 15 | 2020 | 9146 | 0.670 |
Why?
|
Product Surveillance, Postmarketing | 6 | 2020 | 430 | 0.660 |
Why?
|
Splanchnic Circulation | 2 | 2018 | 110 | 0.650 |
Why?
|
Aspartate Aminotransferases | 1 | 2020 | 418 | 0.640 |
Why?
|
Amaurosis Fugax | 1 | 2017 | 7 | 0.630 |
Why?
|
Survival Rate | 22 | 2020 | 12788 | 0.620 |
Why?
|
Hypoglycemic Agents | 3 | 2018 | 2872 | 0.620 |
Why?
|
Anemia | 2 | 2017 | 1506 | 0.620 |
Why?
|
Liver Circulation | 1 | 2018 | 164 | 0.610 |
Why?
|
Recurrence | 23 | 2020 | 8340 | 0.600 |
Why?
|
Clinical Competence | 9 | 2020 | 4687 | 0.600 |
Why?
|
Boston | 14 | 2017 | 9313 | 0.590 |
Why?
|
Platelet Count | 1 | 2020 | 781 | 0.590 |
Why?
|
Hepatic Artery | 1 | 2018 | 245 | 0.570 |
Why?
|
Imaging, Three-Dimensional | 4 | 2018 | 4042 | 0.570 |
Why?
|
Prosthesis-Related Infections | 3 | 2022 | 538 | 0.560 |
Why?
|
Radiation Dosage | 3 | 2023 | 1928 | 0.550 |
Why?
|
Renal Artery Obstruction | 4 | 2016 | 248 | 0.550 |
Why?
|
Pacemaker, Artificial | 1 | 2022 | 816 | 0.550 |
Why?
|
Specialties, Surgical | 2 | 2018 | 391 | 0.530 |
Why?
|
Hospitals | 6 | 2022 | 3952 | 0.530 |
Why?
|
Databases as Topic | 8 | 2011 | 475 | 0.530 |
Why?
|
Fluoroscopy | 4 | 2023 | 924 | 0.520 |
Why?
|
Insulin | 3 | 2018 | 6580 | 0.520 |
Why?
|
Aorta | 6 | 2023 | 2061 | 0.510 |
Why?
|
Workload | 2 | 2018 | 850 | 0.510 |
Why?
|
Hospital Costs | 2 | 2020 | 985 | 0.510 |
Why?
|
Peritoneum | 1 | 2016 | 228 | 0.510 |
Why?
|
Platelet Aggregation Inhibitors | 7 | 2022 | 3068 | 0.500 |
Why?
|
Health Care Costs | 5 | 2017 | 3209 | 0.490 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2017 | 451 | 0.490 |
Why?
|
Drug-Eluting Stents | 5 | 2021 | 753 | 0.480 |
Why?
|
Renal Insufficiency, Chronic | 4 | 2023 | 2208 | 0.480 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2018 | 450 | 0.480 |
Why?
|
Research Personnel | 1 | 2019 | 573 | 0.480 |
Why?
|
Education, Medical, Graduate | 4 | 2020 | 2291 | 0.460 |
Why?
|
Incidence | 19 | 2022 | 20947 | 0.460 |
Why?
|
Abdomen | 1 | 2019 | 1118 | 0.440 |
Why?
|
Renin-Angiotensin System | 1 | 2017 | 759 | 0.440 |
Why?
|
Follow-Up Studies | 25 | 2023 | 39050 | 0.440 |
Why?
|
New England | 16 | 2018 | 1022 | 0.440 |
Why?
|
Constriction, Pathologic | 6 | 2023 | 1107 | 0.430 |
Why?
|
Defibrillators, Implantable | 1 | 2022 | 1440 | 0.420 |
Why?
|
Laparotomy | 4 | 2018 | 473 | 0.410 |
Why?
|
Anesthesia, General | 4 | 2021 | 1171 | 0.410 |
Why?
|
Hematocrit | 3 | 2017 | 636 | 0.410 |
Why?
|
Renal Dialysis | 5 | 2023 | 1786 | 0.400 |
Why?
|
Critical Illness | 13 | 2019 | 2670 | 0.400 |
Why?
|
Ultrasonography, Doppler, Duplex | 7 | 2016 | 205 | 0.390 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 1184 | 0.390 |
Why?
|
Occupational Health | 1 | 2017 | 809 | 0.390 |
Why?
|
Embolectomy | 4 | 2017 | 120 | 0.380 |
Why?
|
Patient Admission | 2 | 2021 | 1380 | 0.380 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2017 | 1518 | 0.380 |
Why?
|
Glomerular Filtration Rate | 3 | 2016 | 2170 | 0.360 |
Why?
|
Embolic Protection Devices | 3 | 2019 | 42 | 0.360 |
Why?
|
Carotid Artery, Internal | 3 | 2013 | 445 | 0.360 |
Why?
|
Surgery, Computer-Assisted | 1 | 2018 | 1018 | 0.360 |
Why?
|
Body Mass Index | 7 | 2018 | 12720 | 0.350 |
Why?
|
Canada | 6 | 2020 | 2065 | 0.350 |
Why?
|
Dyslipidemias | 1 | 2017 | 849 | 0.350 |
Why?
|
Sex Distribution | 3 | 2021 | 2297 | 0.350 |
Why?
|
Surgical Wound Infection | 5 | 2019 | 1540 | 0.340 |
Why?
|
Viscera | 1 | 2010 | 139 | 0.340 |
Why?
|
Collagen Type III | 2 | 2019 | 90 | 0.340 |
Why?
|
Blood Platelets | 1 | 2020 | 2508 | 0.340 |
Why?
|
Thrombosis | 5 | 2021 | 2968 | 0.330 |
Why?
|
Perioperative Period | 4 | 2017 | 256 | 0.330 |
Why?
|
Myocardial Reperfusion Injury | 4 | 2000 | 476 | 0.320 |
Why?
|
Oligosaccharides | 2 | 2000 | 414 | 0.320 |
Why?
|
Ehlers-Danlos Syndrome | 2 | 2019 | 89 | 0.320 |
Why?
|
Kidney | 5 | 2018 | 7186 | 0.310 |
Why?
|
International Classification of Diseases | 1 | 2013 | 867 | 0.310 |
Why?
|
Severity of Illness Index | 16 | 2021 | 15540 | 0.310 |
Why?
|
Intraoperative Complications | 4 | 2020 | 1198 | 0.300 |
Why?
|
Blood Glucose | 2 | 2018 | 6256 | 0.300 |
Why?
|
Occupational Exposure | 1 | 2017 | 1796 | 0.300 |
Why?
|
Coated Materials, Biocompatible | 5 | 2022 | 319 | 0.290 |
Why?
|
Brachial Artery | 1 | 2008 | 369 | 0.290 |
Why?
|
Hematoma | 3 | 2018 | 758 | 0.290 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2018 | 3336 | 0.290 |
Why?
|
Celiac Artery | 3 | 2016 | 69 | 0.280 |
Why?
|
Disease-Free Survival | 10 | 2018 | 6895 | 0.270 |
Why?
|
Lipids | 1 | 2017 | 3305 | 0.270 |
Why?
|
Thinness | 1 | 2009 | 480 | 0.270 |
Why?
|
Advisory Committees | 2 | 2020 | 775 | 0.270 |
Why?
|
Treatment Failure | 4 | 2019 | 2618 | 0.260 |
Why?
|
Aspirin | 4 | 2022 | 3282 | 0.260 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2008 | 277 | 0.260 |
Why?
|
Inpatients | 3 | 2020 | 2518 | 0.260 |
Why?
|
Acute Kidney Injury | 4 | 2022 | 1972 | 0.260 |
Why?
|
Mortality | 5 | 2021 | 2864 | 0.250 |
Why?
|
Obesity | 4 | 2018 | 12745 | 0.250 |
Why?
|
Prosthesis Failure | 4 | 2021 | 1206 | 0.250 |
Why?
|
Societies, Medical | 7 | 2023 | 3743 | 0.250 |
Why?
|
Hypotension | 2 | 2020 | 884 | 0.240 |
Why?
|
Creatinine | 4 | 2018 | 1919 | 0.240 |
Why?
|
American Heart Association | 3 | 2023 | 1056 | 0.230 |
Why?
|
Cost Savings | 3 | 2022 | 926 | 0.230 |
Why?
|
Endothelium, Vascular | 4 | 2006 | 4456 | 0.230 |
Why?
|
Staphylococcal Infections | 1 | 2013 | 1400 | 0.230 |
Why?
|
Kidney Failure, Chronic | 3 | 2018 | 2538 | 0.230 |
Why?
|
Iliac Artery | 4 | 2015 | 364 | 0.220 |
Why?
|
Reproducibility of Results | 8 | 2021 | 19905 | 0.220 |
Why?
|
Preoperative Care | 5 | 2018 | 2250 | 0.220 |
Why?
|
Hemorrhage | 3 | 2022 | 3461 | 0.220 |
Why?
|
Hospitalization | 4 | 2021 | 10262 | 0.220 |
Why?
|
North America | 3 | 2021 | 1249 | 0.210 |
Why?
|
Constriction | 2 | 2019 | 181 | 0.210 |
Why?
|
Mammaplasty | 3 | 2017 | 1204 | 0.210 |
Why?
|
Microcirculation | 1 | 2006 | 1286 | 0.200 |
Why?
|
Upper Extremity | 2 | 2022 | 648 | 0.200 |
Why?
|
Cardiology | 2 | 2023 | 1668 | 0.200 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 2 | 2022 | 687 | 0.200 |
Why?
|
Clavicle | 1 | 2023 | 209 | 0.200 |
Why?
|
Heart Arrest, Induced | 2 | 2000 | 355 | 0.200 |
Why?
|
Technology | 1 | 2023 | 305 | 0.190 |
Why?
|
Tibial Arteries | 2 | 2015 | 57 | 0.190 |
Why?
|
Benchmarking | 4 | 2021 | 1042 | 0.190 |
Why?
|
Disease Progression | 7 | 2018 | 13284 | 0.190 |
Why?
|
Vascular Fistula | 1 | 2020 | 50 | 0.180 |
Why?
|
Cohort Studies | 11 | 2023 | 40561 | 0.180 |
Why?
|
Lung Diseases | 3 | 2021 | 1886 | 0.180 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2021 | 233 | 0.180 |
Why?
|
Quality-Adjusted Life Years | 3 | 2002 | 1683 | 0.180 |
Why?
|
Guideline Adherence | 3 | 2020 | 2266 | 0.180 |
Why?
|
Paraplegia | 1 | 2020 | 168 | 0.180 |
Why?
|
Age Distribution | 3 | 2017 | 2902 | 0.180 |
Why?
|
Prospective Studies | 17 | 2023 | 53288 | 0.180 |
Why?
|
Personnel Selection | 1 | 2021 | 189 | 0.170 |
Why?
|
Linear Models | 4 | 2018 | 5952 | 0.170 |
Why?
|
Intestinal Fistula | 1 | 2020 | 140 | 0.170 |
Why?
|
Hernia, Ventral | 2 | 2013 | 176 | 0.170 |
Why?
|
Public-Private Sector Partnerships | 1 | 2020 | 121 | 0.170 |
Why?
|
Overweight | 1 | 2010 | 2371 | 0.170 |
Why?
|
Carbon Dioxide | 1 | 2023 | 1150 | 0.170 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2020 | 9959 | 0.170 |
Why?
|
Cultural Competency | 1 | 2021 | 289 | 0.160 |
Why?
|
Anesthesia, Conduction | 1 | 2021 | 238 | 0.160 |
Why?
|
Remission, Spontaneous | 1 | 2018 | 382 | 0.160 |
Why?
|
Life Expectancy | 2 | 2017 | 1184 | 0.160 |
Why?
|
Prisoners | 1 | 2021 | 297 | 0.160 |
Why?
|
Blood Pressure | 4 | 2020 | 8554 | 0.150 |
Why?
|
Endoscopy | 1 | 2008 | 1785 | 0.150 |
Why?
|
Cultural Diversity | 1 | 2021 | 359 | 0.150 |
Why?
|
Ankle Brachial Index | 1 | 2018 | 154 | 0.150 |
Why?
|
Cost-Benefit Analysis | 4 | 2017 | 5391 | 0.150 |
Why?
|
Equipment and Supplies | 1 | 2020 | 281 | 0.150 |
Why?
|
Insurance, Health, Reimbursement | 2 | 2020 | 397 | 0.150 |
Why?
|
Dependent Ambulation | 1 | 2017 | 13 | 0.150 |
Why?
|
Body Surface Area | 2 | 2014 | 198 | 0.150 |
Why?
|
Intestines | 2 | 2016 | 1924 | 0.150 |
Why?
|
Adult | 29 | 2020 | 214055 | 0.150 |
Why?
|
Thienopyridines | 1 | 2016 | 12 | 0.150 |
Why?
|
Ambulatory Care | 2 | 2021 | 2708 | 0.150 |
Why?
|
Radiation Monitoring | 1 | 2017 | 98 | 0.150 |
Why?
|
Health Status | 6 | 2019 | 4034 | 0.150 |
Why?
|
Diagnostic Imaging | 3 | 2023 | 3507 | 0.150 |
Why?
|
Prevalence | 4 | 2021 | 15226 | 0.140 |
Why?
|
Models, Cardiovascular | 2 | 2018 | 996 | 0.140 |
Why?
|
Housing | 1 | 2021 | 664 | 0.140 |
Why?
|
Hyperphosphatemia | 1 | 2016 | 40 | 0.140 |
Why?
|
Contrast Media | 2 | 2023 | 5300 | 0.140 |
Why?
|
Aneurysm, False | 2 | 2020 | 276 | 0.140 |
Why?
|
Regional Medical Programs | 1 | 2016 | 71 | 0.140 |
Why?
|
Heparin | 1 | 2023 | 1637 | 0.140 |
Why?
|
Vasodilation | 1 | 2000 | 944 | 0.140 |
Why?
|
Heart | 2 | 2019 | 4467 | 0.140 |
Why?
|
Anesthesia, Local | 1 | 2018 | 275 | 0.130 |
Why?
|
Young Adult | 10 | 2020 | 56430 | 0.130 |
Why?
|
Watchful Waiting | 2 | 2018 | 492 | 0.130 |
Why?
|
Tubulin Modulators | 3 | 2020 | 110 | 0.130 |
Why?
|
Office Visits | 1 | 2020 | 598 | 0.130 |
Why?
|
Acute Disease | 4 | 2019 | 7149 | 0.130 |
Why?
|
Tissue Expansion Devices | 1 | 2016 | 156 | 0.130 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2018 | 11725 | 0.130 |
Why?
|
Physicians, Women | 1 | 2021 | 486 | 0.130 |
Why?
|
Cardiopulmonary Bypass | 1 | 2000 | 1066 | 0.130 |
Why?
|
Rare Diseases | 1 | 2020 | 553 | 0.130 |
Why?
|
Hypothermia, Induced | 1 | 2000 | 752 | 0.130 |
Why?
|
Cardiovascular Diseases | 2 | 2019 | 15165 | 0.130 |
Why?
|
New York | 1 | 2017 | 886 | 0.130 |
Why?
|
Drainage | 1 | 2020 | 1142 | 0.120 |
Why?
|
Clinical Trials as Topic | 2 | 2021 | 7913 | 0.120 |
Why?
|
Stroke Volume | 1 | 2007 | 5007 | 0.120 |
Why?
|
Nerve Block | 1 | 2021 | 644 | 0.120 |
Why?
|
Minority Groups | 1 | 2022 | 1223 | 0.120 |
Why?
|
Hemoglobins | 2 | 2017 | 1534 | 0.120 |
Why?
|
Anesthesia, Epidural | 1 | 2016 | 228 | 0.120 |
Why?
|
Consensus | 2 | 2021 | 2959 | 0.120 |
Why?
|
Thrombectomy | 2 | 2016 | 680 | 0.120 |
Why?
|
Cranial Nerve Injuries | 1 | 2013 | 25 | 0.120 |
Why?
|
Patient Acceptance of Health Care | 1 | 2007 | 3022 | 0.120 |
Why?
|
Perioperative Care | 2 | 2018 | 1002 | 0.120 |
Why?
|
Europe | 4 | 2020 | 3339 | 0.120 |
Why?
|
Metals | 1 | 2018 | 719 | 0.110 |
Why?
|
Evidence-Based Medicine | 3 | 2023 | 3610 | 0.110 |
Why?
|
Secondary Prevention | 1 | 2020 | 1530 | 0.110 |
Why?
|
Fellowships and Scholarships | 2 | 2012 | 1076 | 0.110 |
Why?
|
Equipment Design | 2 | 2020 | 3582 | 0.110 |
Why?
|
Operating Rooms | 1 | 2020 | 817 | 0.110 |
Why?
|
Phosphates | 1 | 2016 | 786 | 0.110 |
Why?
|
Mobility Limitation | 1 | 2017 | 409 | 0.110 |
Why?
|
Staphylococcus epidermidis | 1 | 2013 | 117 | 0.110 |
Why?
|
Residence Characteristics | 2 | 2016 | 2050 | 0.110 |
Why?
|
Breast Implants | 1 | 2016 | 387 | 0.110 |
Why?
|
Thrombolytic Therapy | 1 | 2022 | 2161 | 0.110 |
Why?
|
Respiratory Tract Diseases | 1 | 2018 | 722 | 0.110 |
Why?
|
Erythrocyte Transfusion | 1 | 2017 | 565 | 0.110 |
Why?
|
United States Food and Drug Administration | 1 | 2020 | 1584 | 0.100 |
Why?
|
Hemodynamics | 3 | 2020 | 4199 | 0.100 |
Why?
|
Tissue Adhesions | 1 | 2013 | 235 | 0.100 |
Why?
|
Alloys | 1 | 2012 | 122 | 0.100 |
Why?
|
Ultrasonography | 5 | 2017 | 5985 | 0.100 |
Why?
|
Renal Insufficiency | 1 | 2017 | 804 | 0.100 |
Why?
|
Smoking | 3 | 2018 | 8987 | 0.100 |
Why?
|
Mastectomy | 2 | 2017 | 1793 | 0.100 |
Why?
|
Pre-Eclampsia | 1 | 2020 | 1200 | 0.100 |
Why?
|
Ticlopidine | 1 | 2017 | 899 | 0.100 |
Why?
|
Pain, Postoperative | 1 | 2021 | 1643 | 0.100 |
Why?
|
Body Size | 1 | 2013 | 461 | 0.100 |
Why?
|
Hospitals, University | 1 | 2013 | 571 | 0.090 |
Why?
|
Arteriosclerosis | 3 | 2005 | 1092 | 0.090 |
Why?
|
Dilatation | 2 | 2022 | 291 | 0.090 |
Why?
|
DNA Mutational Analysis | 1 | 2019 | 4186 | 0.090 |
Why?
|
Sheep | 4 | 2000 | 1437 | 0.090 |
Why?
|
Internship and Residency | 3 | 2018 | 5788 | 0.090 |
Why?
|
Regional Blood Flow | 3 | 2020 | 1525 | 0.090 |
Why?
|
New Zealand | 2 | 2020 | 355 | 0.090 |
Why?
|
Cerebrovascular Circulation | 1 | 2020 | 2731 | 0.090 |
Why?
|
Respiration | 1 | 2016 | 1653 | 0.090 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2017 | 949 | 0.090 |
Why?
|
Life Tables | 3 | 2017 | 370 | 0.090 |
Why?
|
Adolescent | 8 | 2019 | 85781 | 0.090 |
Why?
|
Models, Theoretical | 1 | 2021 | 3589 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2020 | 10943 | 0.080 |
Why?
|
Germany | 2 | 2022 | 862 | 0.080 |
Why?
|
Magnetic Resonance Angiography | 4 | 2019 | 1442 | 0.080 |
Why?
|
Cold Temperature | 1 | 2012 | 772 | 0.080 |
Why?
|
Anticoagulants | 3 | 2022 | 4599 | 0.080 |
Why?
|
Intubation, Intratracheal | 1 | 2016 | 1364 | 0.080 |
Why?
|
Radiography | 3 | 2012 | 7023 | 0.080 |
Why?
|
Heart Arrest | 1 | 2018 | 1470 | 0.080 |
Why?
|
Delirium | 1 | 2019 | 1609 | 0.080 |
Why?
|
Surgical Flaps | 1 | 2016 | 1640 | 0.080 |
Why?
|
Survivors | 1 | 2018 | 2291 | 0.080 |
Why?
|
Pain | 1 | 2023 | 4986 | 0.080 |
Why?
|
Terminology as Topic | 1 | 2015 | 1547 | 0.080 |
Why?
|
Attitude of Health Personnel | 1 | 2021 | 3843 | 0.070 |
Why?
|
Prognosis | 4 | 2022 | 29063 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 4 | 2014 | 20129 | 0.070 |
Why?
|
England | 2 | 2020 | 522 | 0.070 |
Why?
|
Forecasting | 1 | 2016 | 2951 | 0.070 |
Why?
|
Dilatation, Pathologic | 2 | 2022 | 520 | 0.070 |
Why?
|
Intestinal Obstruction | 1 | 2010 | 424 | 0.070 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2021 | 3923 | 0.070 |
Why?
|
Medication Adherence | 1 | 2018 | 2063 | 0.070 |
Why?
|
Life Style | 1 | 2018 | 3835 | 0.070 |
Why?
|
Lymphocytes | 1 | 2014 | 2617 | 0.070 |
Why?
|
Animals, Newborn | 3 | 2000 | 2726 | 0.070 |
Why?
|
Atherosclerosis | 2 | 2014 | 3445 | 0.070 |
Why?
|
Cause of Death | 3 | 2020 | 3584 | 0.060 |
Why?
|
Breast Neoplasms | 3 | 2017 | 20822 | 0.060 |
Why?
|
Massachusetts | 2 | 2019 | 8663 | 0.060 |
Why?
|
Internationality | 2 | 2021 | 1003 | 0.060 |
Why?
|
Population Surveillance | 2 | 2020 | 2616 | 0.060 |
Why?
|
Mesentery | 1 | 2005 | 205 | 0.060 |
Why?
|
Hypertension, Renovascular | 1 | 2005 | 123 | 0.060 |
Why?
|
Biomedical Research | 1 | 2020 | 3309 | 0.060 |
Why?
|
Health Services Accessibility | 1 | 2021 | 5137 | 0.060 |
Why?
|
Primary Health Care | 1 | 2020 | 4558 | 0.060 |
Why?
|
Atherectomy | 1 | 2023 | 47 | 0.060 |
Why?
|
Biocompatible Materials | 1 | 2012 | 1736 | 0.060 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2886 | 0.060 |
Why?
|
Transplantation, Autologous | 2 | 2019 | 2124 | 0.060 |
Why?
|
Reference Values | 2 | 2021 | 4982 | 0.050 |
Why?
|
Laparoscopy | 1 | 2015 | 2151 | 0.050 |
Why?
|
Hypercholesterolemia | 1 | 2009 | 1151 | 0.050 |
Why?
|
Quality of Health Care | 1 | 2018 | 4371 | 0.050 |
Why?
|
Gastroesophageal Reflux | 1 | 2009 | 782 | 0.050 |
Why?
|
Research Design | 3 | 2017 | 5987 | 0.050 |
Why?
|
Gold | 1 | 2005 | 484 | 0.050 |
Why?
|
Algorithms | 1 | 2022 | 13881 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2013 | 8642 | 0.050 |
Why?
|
Foot | 1 | 2004 | 527 | 0.050 |
Why?
|
State Medicine | 1 | 2022 | 217 | 0.050 |
Why?
|
Hungary | 1 | 2020 | 84 | 0.050 |
Why?
|
Nitroprusside | 1 | 2000 | 275 | 0.050 |
Why?
|
Survival Analysis | 5 | 2013 | 10252 | 0.040 |
Why?
|
Research Report | 1 | 2022 | 355 | 0.040 |
Why?
|
Decision Trees | 1 | 2021 | 506 | 0.040 |
Why?
|
Singapore | 1 | 2020 | 295 | 0.040 |
Why?
|
Ulcer | 1 | 2020 | 209 | 0.040 |
Why?
|
Delphi Technique | 1 | 2022 | 778 | 0.040 |
Why?
|
Foreign-Body Migration | 1 | 2021 | 222 | 0.040 |
Why?
|
Dissection | 1 | 2020 | 295 | 0.040 |
Why?
|
Norway | 1 | 2020 | 448 | 0.040 |
Why?
|
Lumbar Vertebrae | 1 | 2008 | 1848 | 0.040 |
Why?
|
Spinal Fusion | 1 | 2008 | 1241 | 0.040 |
Why?
|
Finland | 1 | 2020 | 602 | 0.040 |
Why?
|
Femoral Vein | 1 | 2019 | 159 | 0.040 |
Why?
|
Drug Administration Schedule | 2 | 2017 | 4933 | 0.040 |
Why?
|
Multilevel Analysis | 1 | 2018 | 142 | 0.040 |
Why?
|
Polytetrafluoroethylene | 1 | 2019 | 233 | 0.040 |
Why?
|
Acetylcholine | 1 | 2000 | 621 | 0.040 |
Why?
|
Kidney Transplantation | 1 | 2013 | 4251 | 0.040 |
Why?
|
Pressure | 1 | 2001 | 1203 | 0.040 |
Why?
|
Coma | 1 | 2022 | 475 | 0.040 |
Why?
|
Neutrophils | 2 | 2000 | 3719 | 0.040 |
Why?
|
After-Hours Care | 1 | 2018 | 102 | 0.040 |
Why?
|
Lung | 1 | 2016 | 9856 | 0.040 |
Why?
|
Denmark | 1 | 2020 | 738 | 0.040 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2005 | 1873 | 0.040 |
Why?
|
Pulmonary Circulation | 1 | 2000 | 739 | 0.040 |
Why?
|
Physical Examination | 1 | 2023 | 1237 | 0.040 |
Why?
|
Recovery of Function | 2 | 2021 | 2925 | 0.040 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2021 | 624 | 0.040 |
Why?
|
Italy | 1 | 2019 | 832 | 0.040 |
Why?
|
Australia | 1 | 2020 | 1170 | 0.040 |
Why?
|
Peroxidase | 1 | 2000 | 611 | 0.040 |
Why?
|
Analysis of Variance | 2 | 2010 | 6365 | 0.040 |
Why?
|
Universities | 1 | 2022 | 956 | 0.040 |
Why?
|
Cerebrovascular Disorders | 2 | 2015 | 1504 | 0.040 |
Why?
|
Colectomy | 1 | 2022 | 683 | 0.040 |
Why?
|
Sweden | 1 | 2020 | 1345 | 0.040 |
Why?
|
Selectins | 1 | 1996 | 102 | 0.040 |
Why?
|
Renal Replacement Therapy | 1 | 2018 | 257 | 0.040 |
Why?
|
Markov Chains | 1 | 2000 | 969 | 0.030 |
Why?
|
Anastomosis, Surgical | 1 | 2020 | 987 | 0.030 |
Why?
|
Pregnancy | 3 | 2023 | 29144 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2000 | 1616 | 0.030 |
Why?
|
Vasodilator Agents | 1 | 2000 | 977 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2024 | 25043 | 0.030 |
Why?
|
Comparative Effectiveness Research | 1 | 2021 | 681 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2020 | 5078 | 0.030 |
Why?
|
Surgical Wound Dehiscence | 1 | 2016 | 215 | 0.030 |
Why?
|
Myocardial Reperfusion | 1 | 1996 | 351 | 0.030 |
Why?
|
Myocardial Contraction | 1 | 2000 | 1585 | 0.030 |
Why?
|
Organ Size | 1 | 2020 | 2252 | 0.030 |
Why?
|
Mutation | 1 | 2019 | 29786 | 0.030 |
Why?
|
Diabetes Complications | 2 | 2015 | 1359 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2020 | 1462 | 0.030 |
Why?
|
Breast Implantation | 1 | 2017 | 218 | 0.030 |
Why?
|
Inflammation | 1 | 2014 | 10638 | 0.030 |
Why?
|
Patient Care Planning | 1 | 2020 | 921 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 12959 | 0.030 |
Why?
|
Postpartum Period | 1 | 2020 | 1086 | 0.030 |
Why?
|
Animals | 5 | 2019 | 168757 | 0.030 |
Why?
|
Hypertension | 2 | 2014 | 8480 | 0.030 |
Why?
|
Cell Adhesion | 1 | 2000 | 3144 | 0.030 |
Why?
|
International Cooperation | 1 | 2020 | 1420 | 0.030 |
Why?
|
Syndrome | 1 | 2019 | 3251 | 0.030 |
Why?
|
Netherlands | 1 | 2018 | 2170 | 0.030 |
Why?
|
Preoperative Period | 1 | 2015 | 549 | 0.030 |
Why?
|
Models, Economic | 1 | 2017 | 713 | 0.030 |
Why?
|
Mechanics | 1 | 2012 | 15 | 0.030 |
Why?
|
Antibiotic Prophylaxis | 1 | 2018 | 639 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2018 | 1681 | 0.030 |
Why?
|
Fibrinolytic Agents | 1 | 2022 | 2158 | 0.030 |
Why?
|
Regression Analysis | 1 | 2021 | 6459 | 0.020 |
Why?
|
Pain Measurement | 1 | 2021 | 3420 | 0.020 |
Why?
|
Postoperative Period | 1 | 2015 | 1842 | 0.020 |
Why?
|
Models, Biological | 1 | 2006 | 9583 | 0.020 |
Why?
|
Guidelines as Topic | 1 | 2016 | 1405 | 0.020 |
Why?
|
Polysaccharides | 1 | 1996 | 1053 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2019 | 2564 | 0.020 |
Why?
|
Area Under Curve | 1 | 2013 | 1654 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2016 | 1827 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2017 | 3616 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2015 | 950 | 0.020 |
Why?
|
Coronary Vessels | 1 | 2000 | 3107 | 0.020 |
Why?
|
Hemostasis, Surgical | 1 | 2008 | 128 | 0.020 |
Why?
|
Nursing Homes | 1 | 2015 | 1036 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2015 | 1504 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2018 | 2759 | 0.020 |
Why?
|
Body Height | 1 | 2013 | 1577 | 0.020 |
Why?
|
Up-Regulation | 1 | 2016 | 4217 | 0.020 |
Why?
|
Echocardiography | 1 | 2019 | 5102 | 0.020 |
Why?
|
Genetic Testing | 1 | 2019 | 3444 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6489 | 0.020 |
Why?
|
Mesenteric Artery, Inferior | 1 | 2005 | 15 | 0.020 |
Why?
|
Stainless Steel | 1 | 2005 | 80 | 0.020 |
Why?
|
Curriculum | 1 | 2018 | 3605 | 0.020 |
Why?
|
Analgesics, Opioid | 1 | 2021 | 3674 | 0.020 |
Why?
|
Probability | 1 | 2010 | 2505 | 0.020 |
Why?
|
New Hampshire | 1 | 2004 | 172 | 0.020 |
Why?
|
Device Approval | 1 | 2006 | 163 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2017 | 3229 | 0.010 |
Why?
|
Computer Simulation | 1 | 2017 | 6196 | 0.010 |
Why?
|
Suture Techniques | 1 | 2008 | 798 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2017 | 7785 | 0.010 |
Why?
|
Communication | 1 | 2017 | 3749 | 0.010 |
Why?
|
Ventricular Function, Left | 1 | 1995 | 3670 | 0.010 |
Why?
|
Body Weight | 1 | 2013 | 4669 | 0.010 |
Why?
|
Heart Diseases | 1 | 2016 | 2788 | 0.010 |
Why?
|
Tomography, Spiral Computed | 1 | 2003 | 280 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16365 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2016 | 11031 | 0.010 |
Why?
|
ROC Curve | 1 | 2009 | 3527 | 0.010 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2015 | 3047 | 0.010 |
Why?
|
Coronary Circulation | 2 | 1996 | 1572 | 0.010 |
Why?
|
Heart Failure | 2 | 2015 | 10900 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2003 | 1590 | 0.010 |
Why?
|
Intraoperative Care | 1 | 2002 | 767 | 0.010 |
Why?
|
Blood Flow Velocity | 1 | 2002 | 1423 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2016 | 5319 | 0.010 |
Why?
|
Observer Variation | 1 | 2004 | 2593 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 17446 | 0.010 |
Why?
|
Brain | 1 | 2004 | 26385 | 0.010 |
Why?
|
Infant | 1 | 2019 | 35136 | 0.010 |
Why?
|
Nutritional Status | 1 | 2005 | 1609 | 0.010 |
Why?
|
Aging | 1 | 1995 | 8664 | 0.010 |
Why?
|
Child, Preschool | 1 | 2019 | 41006 | 0.010 |
Why?
|
Hypothermia | 1 | 1995 | 189 | 0.010 |
Why?
|
Leukocyte Count | 1 | 1996 | 1588 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 1996 | 1375 | 0.010 |
Why?
|
Child | 1 | 2019 | 77709 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 1996 | 1869 | 0.010 |
Why?
|
Software | 1 | 2003 | 4443 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2002 | 14722 | 0.000 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2003 | 8949 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 1996 | 18029 | 0.000 |
Why?
|